AeroCare Holdings to Become a Publicly Traded Company via Merger with MergeWorthRx

 AeroCare Holdings to Become a Publicly
Traded Company via Merger with
MergeWorthRx October 15, 2014 - AeroCare Holdings Inc., (“AeroCare”)
one of the nation’s leading providers of oxygen,
respiratory and other chronic therapy services to patients
in the home, announced that it has entered into a
definitive agreement to become a publicly traded
company via a merger with MergeWorthRx Corp.
(NASDAQ: MWRX), a special purpose acquisition
company (“SPAC”) focused on the U.S. health care
services market. AeroCare is a portfolio company of
Ferrer, Freeman & Company, LLC and MTS Health
Partners, LP. The transaction is expected to close by the
end of the fourth quarter of 2014.
Founded in 2002, Orlando, FL-based AeroCare, together with its subsidiaries, provides oxygen,
respiratory, sleep and other chronic therapy services to more than 150,000 patients in the home
through a network of 175 locations across 20 U.S. states. The Company’s patients typically suffer
from chronic obstructive pulmonary disease (“COPD”), such as emphysema, chronic bronchitis or
asthma, and require supplemental oxygen, respiratory and other chronic therapy services in order to
alleviate the symptoms and discomfort of respiratory dysfunction. The Company also provides sleep
apnea devices, including CPAP/bi-level devices to individuals suffering from obstructive sleep apnea
(“OSA”).
AeroCare retained Cain Brothers as its exclusive financial advisor in connection with its merger with
MergeWorthRx.
MergeWorthRx is a SPAC formed on January 22, 2013, for the purpose of entering into a merger,
share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar
business combination with one or more target businesses, with specific investment focus on the U.S.
health care industry. MergeWorthRx raised approximately $63.5 million in its IPO in July 2013 and
its common stock is traded on NASDAQ under the ticker symbol MWRX.
If you would like more information about this transaction, please feel free to contact: MATTHEW MARGULIES
Managing Director
212-981-6938
mmargulies@cainbrothers.com
Cain Brothers is an independent investment banking firm that focuses exclusively on the health care industry. Our clients include
investor-owned and tax-exempt providers, insurers and payers, health care information and medical technology companies, and
private equity and venture capital firms. We have one of the largest teams of experienced health care bankers and capital markets
professionals on Wall Street. Operating out of offices across the country, Cain Brothers provides mergers & acquisitions, capital
raising, real estate, and strategic and financial advisory solutions to our clients.
©2014 Cain Brothers & Company, LLC, 360 Madison Avenue, New York, NY 10017 All rights reserved.